| HOME >> MEDICINE >> TECHNOLOGY |
THERMOGENESIS CORP.Condensed Consolidated Balance Sheets
(Unaudited)June 30,
2011June 30,
2010ASSETSCurrent assets: Cash and cash equivalents$12,309,000$10,731,000 Accounts receivable, net3,963,0006,095,000 Inventories6,348,0005,034,000 Other current assets420,000301,000Total current assets23,040,00022,161,000 Equipment, net1,310,0001,701,000 Other assets49,000168,000$24,399,000$24,030,000LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities: Accounts payable$1,791,000$2,383,000 Other current liabilities2,273,0003,191,000Total current liabilities4,064,0005,574,000Long-term liabilities242,000677,000Stockholders' equity20,093,00017,779,000$24,399,000$24,030,000THERMOGENESIS CORP.Condensed Consolidated Statements of Operations
(Unaudited)Three Months Ended
June 30,Year Ended
June 30,2011201020112010Net revenues
$5,378,000$7,176,000$23,400,000$23,088,000Cost of revenues
3,512,0004,700,00014,563,00015,643,000Gross profit
1,866,0002,476,0008,837,0007,445,000Expenses: Selling, general and administrative
2,245,0001,711,0008,669,0007,686,000 Research and development
789,000939,0003,003,0005,013,000Total operating expenses
3,034,0002,650,00011,672,00012,699,000Interest and other income, net
--3,000268,00061,000Net loss
($1,168,000)($171,000)($2,567,000)($5,193,000)Basic and diluted net loss per common
share
($0.07)($0.01)($0.17)($0.37)Shares used in computing per share data
16,346,36614,023,24014,816,16314,023,240THERMOGENESIS CORP.Condensed Consolidated Statements of Cash Flows
(Unaudited)Year Ended
June 30,20112010Cash flows from operating activities: Net loss
($2,567,000)($5,193,000) Adjustments to reconcile net loss to net cash used
in operating activities:Depreciation and amortization
466,000492,000Stock based compensation e
'/>"/>
| SOURCE ThermoGenesis Corp. Copyright©2010 PR Newswire. All rights reserved |